Similar articles for PMID: 28064217

Year	Number of Results
2002	1
2003	1
2005	2
2006	5
2007	11
2008	7
2009	4
2010	7
2011	7
2012	8
2013	3
2014	7
2015	2
2016	7
2017	4
2018	4
2020	5
2022	1
2023	2

1

Clinical Factors Asssociated with Treatment Outcomes following Whole-brain Irradiation in Patients with Prostate Cancer.

Dziggel L, Schild SE, Veninga T, Bajrovic A, Rades D. Dziggel L, et al. In Vivo. 2017 Jan 2;31(1):35-38. doi: 10.21873/invivo.11021. In Vivo. 2017. PMID: 28064217 Free PMC article. Review.

2

Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.

Rades D, Kueter JD, Meyners T, Pluemer A, Veninga T, Gliemroth J, Schild SE. Rades D, et al. Clin Neurol Neurosurg. 2012 May;114(4):326-30. doi: 10.1016/j.clineuro.2011.10.042. Epub 2011 Dec 5. Clin Neurol Neurosurg. 2012. PMID: 22152784

3

Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.

Rades D, Veninga T, Hornung D, Wittkugel O, Schild SE, Gliemroth J. Rades D, et al. Cancer. 2012 Feb 15;118(4):1138-44. doi: 10.1002/cncr.26379. Epub 2011 Jul 14. Cancer. 2012. PMID: 21761403 Free article.

4

Potential Impact of the Overall Treatment Time on Outcomes after Whole-brain Irradiation with 10×3 Gy for Brain Metastases.

Rades D, Janssen S, Veninga T, Schild SE. Rades D, et al. Anticancer Res. 2016 Jun;36(6):3071-4. Anticancer Res. 2016. PMID: 27272829

5

Predicting survival after whole-brain irradiation for cerebral metastases from prostate cancer.

Bartscht T, Rades D. Bartscht T, et al. Anticancer Res. 2014 Aug;34(8):4357-60. Anticancer Res. 2014. PMID: 25075071

6

Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).

Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Dunst J. Rades D, et al. Strahlenther Onkol. 2007 Nov;183(11):631-6. doi: 10.1007/s00066-007-1763-5. Strahlenther Onkol. 2007. PMID: 17960339

7

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.

Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJ, Schild SE, Rades D. Meyners T, et al. BMC Cancer. 2010 Oct 26;10:582. doi: 10.1186/1471-2407-10-582. BMC Cancer. 2010. PMID: 20977700 Free PMC article.

8

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.

Rades D, Janssen S, Dziggel L, Blanck O, Bajrovic A, Veninga T, Schild SE. Rades D, et al. BMC Cancer. 2017 Jan 6;17(1):30. doi: 10.1186/s12885-016-2989-3. BMC Cancer. 2017. PMID: 28061768 Free PMC article.

9

Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.

Rades D, Lohynska R, Veninga T, Stalpers LJ, Schild SE. Rades D, et al. Cancer. 2007 Dec 1;110(11):2587-92. doi: 10.1002/cncr.23082. Cancer. 2007. PMID: 17893909 Free article.

10

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Viani GA, Castilho MS, Salvajoli JV, Pellizzon AC, Novaes PE, Guimarães FS, Conte MA, Fogaroli RC. Viani GA, et al. BMC Cancer. 2007 Mar 26;7:53. doi: 10.1186/1471-2407-7-53. BMC Cancer. 2007. PMID: 17386108 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year